Sequencing Healthy Patients Reveals That Many Carry Rare Genetic Disease Risks

June 27, 2017 | In a new paper published in the Annals of Internal Medicine, investigators at Brigham and Women's Hospital and Harvard Medical School, along with collaborators at Baylor College of Medicine, report the results of the 4 year, NIH-funded MedSeq Project, the first-ever randomized trial conducted to examine the impact of whole genome sequencing in healthy primary care patients. Bio-IT World